The global Point
of Care Diagnostics Market is driven by technological improvements and
introduction of sophisticated medical solutions. A host of healthcare
establishments are gradually taking to point of care tests and diagnostics
solutions for greater efficiency. Growing popularity of EMR (electronic medical
record) and PACS (picture archiving and communication systems) has a positive
impact on market demand.
Other industry drivers are governmental support,
surging healthcare investments, growing geriatric population, and widespread
adoption of home based POC devices. When medical diagnostics tests are carried
out at the place of patient care, it is known as bedside testing or POCT
(point-of-care-testing). New product development is a vital factor that may
contribute significantly to market growth during the forecast period (2012 to
2020).
Browse Details of Report @ https://www.hexaresearch.com/research-report/point-of-care-diagnostics-industry
Products, end users, and regions are the parameters
based on which the global point of care (POC) diagnostics industry is
categorized. As per products, the segments are blood gas/electrolytes,
fertility, cardiac markers, OTC & rapid diagnostic tests, infectious
diseases, coagulation, drug abuse testing, hospital glucose testing,
decentralized clinical chemistry, hematology, and urinalysis. Products also
include primary care systems, such as HbA1c tests and lipid profiling. Hospital
glucose testing holds the highest market share.
Factors that propel this segment are high incidence of
diabetes and the growing necessity for glucose analysis on a regular basis.
The OTC & rapid diagnostic tests market may expand
robustly over the forecast period because of the “self diagnosis” trend. People
nowadays are highly aware of the importance of early disease diagnosis for
on-time & instant disease treatment. Based on end users, the global
industry is divided into laboratories, hospitals, clinics, assisted living
healthcare facilities, homes, and others. Hospitals & clinics generate
highest revenues in the overall market. Diagnostic tests are mostly conducted
in clinics and in hospitals. As a result, most of these healthcare centers have
begun expanding their POC diagnostic facilities.
Geographically, the worldwide Point Of Care
Diagnostics Market is categorized into Asia Pacific, Europe, North America, and
Rest of the World (RoW). North America is the largest regional industry. High
degree of patient awareness, encouraging government initiatives, and
substantial investments in medical infrastructure are prominent regional
drivers. It is however, expected that Asia Pacific will register the highest
growth rate over the forecast period. This attributes to improvements in
healthcare infrastructure in emerging countries, such as India and China.
Companies operating in the global Point Of Care
Diagnostics Market continuously strive towards capturing higher market shares.
They invest robustly in R&D and product innovations. Prominent market
competitors are Trinity Biotech PLC, Danaher Corporation, Siemens Healthcare,
Roche Diagnostics, and Becton Dickinson and Company.
In September 2016, Novartis launched the NijiTM System
and Total IgE Test, a POC diagnostic tool. By using just a droplet or two of
finer stick blood, this device delivers Immunoglobulin E (IgE) levels in a
matter of twelve minutes. This test caters to immediate in-office diagnosis of
allergies associated with IgE levels. The availability of such tests in the
offices of healthcare providers leads to reduced time for consultation,
diagnosis, prognosis, and disease treatment. This in turn leads to better
patient outcomes.
Get Sample Copy of this Report @ Point
of Care (POC) Diagnostics Market
About Us:
Hexa Research is a market research and
consulting organization, offering industry reports, custom research and
consulting services to a host of key industries across the globe. We offer
comprehensive business intelligence in the form of industry reports which help
our clients obtain clarity about their business environment and enable them to
undertake strategic growth initiatives.
Contact Us:
Ryan Shaw
Hexa Research
Felton Office Plaza
6265 Highway 9
Felton, California 95018
United States
Phone: +1-800-489-3075
Website - https://www.hexaresearch.com
No comments:
Post a Comment